57 min

Episode 22 - Dr. Michael Hayden and PROOF-HD HD Insights Podcast

    • Science

Dr. Michael Hayden, Chief Executive Officer for Prilenia Therapeutics, and a Killam Professor at the University of British Columbia, joined the HD Insights Podcast to discuss the PROOF-HD clinical study. Prilenia (https://www.prilenia.com) is sponsor for the currently active PROOF-HD trial, a global study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease. Dr. Hayden spoke about this new study's unique endpoint for total functional capacity. You will also want to hear his inspiring personal journey that led him into Huntington disease research growing up in South Africa. 

For more information on PROOF-HD, visit https://huntingtonstudygroup.org/proof-hd/.

Dr. Michael Hayden, Chief Executive Officer for Prilenia Therapeutics, and a Killam Professor at the University of British Columbia, joined the HD Insights Podcast to discuss the PROOF-HD clinical study. Prilenia (https://www.prilenia.com) is sponsor for the currently active PROOF-HD trial, a global study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease. Dr. Hayden spoke about this new study's unique endpoint for total functional capacity. You will also want to hear his inspiring personal journey that led him into Huntington disease research growing up in South Africa. 

For more information on PROOF-HD, visit https://huntingtonstudygroup.org/proof-hd/.

57 min

Top Podcasts In Science

Hidden Brain
Alie Ward
Bloomberg
Neil deGrasse Tyson
NPR
Sam Harris